Vertical transmission of hepatitis B virus: challenges and solutions
- PMID: 24966696
- PMCID: PMC4062549
- DOI: 10.2147/IJWH.S51138
Vertical transmission of hepatitis B virus: challenges and solutions
Abstract
More than 240 million people worldwide are chronically infected with hepatitis B virus (HBV). Mother-to-child transmission remains the most important mechanism of infection in countries with a high prevalence of HBV. Universal screening of all pregnant women, at-birth prophylaxis with specific anti-HBV immune globulin, as well as HBV vaccination for newborns of infected mothers are effective in reducing the risk of vertical transmission. However, in cases of a high viral load and hepatitis B e antigen positivity, there is a residual risk of HBV transmission to the newborn despite prophylaxis. This review focuses on the above-indicated strategies and on the efficacy and safety of antiviral drugs administered during the third trimester of pregnancy.
Keywords: immune globulin; prophylaxis; telbuvidine; tenofovir; vaccine; viral load.
References
-
- World Health Organization [webpage on the Internet] Hepatitis B. Geneva, Switzerland: World Health Organization; 2013. [Accessed May 30, 2014]. [updated July 2013]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/index.html.
-
- Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009;29(Suppl 1):133–139. - PubMed
-
- Lavanchy D. Chronic viral hepatitis as a public health issue in the world. Best Pract Res Clin Gastroenterol. 2008;22(6):991–1008. - PubMed
-
- Coppola N, Loquercio G, Tonziello G, et al. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. J Clin Virol. 2013;58(1):315–317. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
